Submitted by Anonymous (not verified) on 6 October 2025 - 8:50
Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 3, Status: Authorised
Source: